LIPODYSTROPHY
Clinical trials for LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lifeline drug access for rare fat disorder patients
Disease control OngoingThis study provides continued access to the drug metreleptin for people with partial lipodystrophy, a rare condition that causes severe diabetes and high blood fats. It is for patients who have already benefited from the drug in past NIH studies but cannot get it through regular …
Matched conditions: LIPODYSTROPHY
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Lifeline for rare disease patients denied access to vital drug
Disease control OngoingThis study provides continued access to the drug metreleptin for people with a rare condition called generalized lipodystrophy who have previously received it through NIH research and cannot get it through normal channels in their home country. It aims to monitor the long-term sa…
Matched conditions: LIPODYSTROPHY
Phase: PHASE3 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC